Our Portfolio
Our portfolio reflects the scale and diversity of the broader healthcare venture capital market.
For over 13 years, we have created customized solutions for venture funds, corporate venture funds, limited partnership interests, operating companies, and individual shareholders.
Preventice Solutions focuses on mobile health solutions and remote monitoring services. It was acquired by Boston Scientific in 2021.
Acutus Medical is a dynamic arrhythmia care company leading the charge in the EP Revolution Ultra High Resolution Imaging and Mapping System. IPO in 2020, NASDAQ: AFIB
Labcyte Inc. is a laboratory instrumentation company with a novel approach to dispensing small volumes of liquids for life sciences applications. It was acquired by Beckman Coulter Life Sciences in 2019.
Torax Medical, Inc. develops and markets products designed to treat sphincter disorders utilizing its technology platform, Magnetic Sphincter Augmentation (MSA). It was acquired by Johnson & Johnson's Ethicon in 2017.
iRhythm is a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed. IPO in 2016 (NASDAQ: IRTC).
SurgiQuest Inc. develops, manufactures and markets innovative access technologies for minimally invasive surgery. It was acquired by ConMed in 2016.
Veran's SPiN Thoracic Navigation System® is revolutionizing bronchoscopy and transforming the standard of care for early lung cancer diagnoses.
Liquidia is a late-stage clinical biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary PRINT® technology.
DiscoverX provides innovative cell-based assays and services for drug discovery and development. It was acquired by Eurofins Pharma Discovery Services (EPDS) in 2017.
Corventis is a pioneer in wearable, wireless technologies for cardiac disease. It was acquired by Medtronic in 2014.
Advanced Surgical Concepts focuses on offering a high quality, service oriented environment for surgical procedures.
Pulsar Vascular Inc developed the PulseRider minimally invasive, self-expanding nitinol implant. It was acquired by Codman Neuro in 2016.
TransMedics, Inc. is a medical device company founded to address the unmet need for more and better organs for transplantation. IPO in 2019 (NASDAQ: TMDX).
QuatRx is focused on development of therapeutics for endocrine and metabolic diseases. It was acquired by Shionogi Pharma Inc. in 2017.
Akebia is focused on the development of therapeutics based on hypoxia-inducible factor biology. IPO in 2014 (NASDAQ: AKBA).
Wellpartner is a leading provider of 340B Drug Pricing Program services It was acquired by CVS Health in 2018.
Aerpio Pharmaceuticals focuses on leveraging Tie2 activation for ocular disease and vascular stabilization. IPO in 2018 (NASDAQ: ARPO).
Counsyl is a health technology company that offers DNA screening for men, women, and their children. It was acquired by Myriad Genetics in 2018.
Esperion Therapeutics
focuses on the development of bempedoic acid. IPO in 2013 (NASDAQ: ESPR).
AcelRx Pharmaceuticals focuses on the development and commercialization of innovative therapies. IPO in 2011 (NASDAQ: ACRX).
Iora Health is transforming health care through a high-impact relationship based care model, that particularly benefits older adults on Medicare.
Oxford Nanopore Technologies is developing and selling nanopore sequencing products for the direct, electronic analysis of single molecules.
A global leader in interventional pulmonology, planning tools, and treatments for obstructive lung disease.
Progyny is a fertility benefits management company providing inclusive fertility solutions to benefit employers, patients, and physicians.
Adaptive Biotechnologies is a leader in immune-driven medicine. IPO in 2019, NASDAQ: ADPT.
ClearCorrect is a clear aligner system used to straighten teeth as an alternative to traditional braces. It was acquired by Straumann Group in 2017.
Crescendo Bioscience develops diagnostic tools for rheumatologists to manage patients with autoimmune and inflammatory diseases. It was acquired by Myriad Genetics in 2014.
Endologix, Inc. is singularly focused on providing innovative, minimally invasive technologies for aortic disorders. IPO in 2018 (NASDAQ: ELGX).
NOVADAQ is a leading developer of fluorescence imaging technology. It was acquired by Stryker Corporation in 2017.
ViewRay, Inc. designs, manufactures, and markets the MRIdian® radiation therapy system. IPO in 2015 (NASDAQ: VRAY).
Inivata is a leader in liquid biopsy. Its InVision® platform unlocks key genomic information from a simple blood test to transforming patient cancer care.
